Psilocybin, the psychedelic compound present in hallucinogenic mushrooms, could repair the brain damage caused by cranial trauma

Psilocybin, the psychedelic compound present in hallucinogenic mushrooms, could have positive effects in repairing brain damage caused by cranial trauma: the results of a new study

A new search could revolutionize the treatment of mild brain lesionssuggesting that the psilocybinethe psychedelic compound present in hallucinogenic mushroomscould have positive effects in repair brain damage caused by cranial trauma.

Although the heads, even minors, have long been associated with serious neurological problems such as dementia, Parkinson’s disease and chronic traumatic encephalopathy (CTE), to deal with such damage. However, a study conducted by researchers from Northeastern University showed surprising results.

The researchers subjected some female rats with slight cranial trauma and subsequently administered psilocybine to them. The results of brain scans through magnetic resonance imaging (MRI) have been extremely promising. The rats that had received the treatment not only had shown Signs of recovery from the damage sufferedbut their neural networks were also more connected than before. This suggests that psilocybin could encourage neuroplasticity, a process that helps the brain to reorganize itself and recover from structural damage.

Treatment with psilocybin seems to significantly reduce cerebral inflammation

In particular, the treatment with psilocybin Cerebral inflammation seems to significantly reducea critical factor in many types of traumatic lesions. While the untreated rats showed signs of cerebral swelling, in the group treated with psilocybin The swelling was significantly reduced.

This shows not only the effectiveness of psilocybin in treating slight injuries, but also its potential in facing brain damage caused by repeated lesions, which are frequent in contact sports and between military veterans. These results could open the way to New therapeutic options for people who suffer repeated cranial traumaa condition that afflicts millions of individuals, in particular professional and military athletes.

Even if the research is still in the preliminary phase and has not received a complete revision, the data suggest that psilocybine, thanks to its ability to reduce inflammation and improve brain connectivity, could represent a hope For the treatment of slight brain lesions and for the prevention of neurodegenerative diseases linked to these traumas.